专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明申请

US20130005770A1 ORGANIC COMPOUNDS 有权
标题翻译：有机化合物
公开(公告)号：US20130005770A1
公开(公告)日：2013-01-03
申请号：US13616081
申请日：2012-09-14
申请人： Fumiaki Yokokawa , Takeru Ehara , Shimpei Kawakami , Osamu Irie , Masaki Suzuki , Yuko Hitomi , Atsushi Toyao
发明人： Fumiaki Yokokawa , Takeru Ehara , Shimpei Kawakami , Osamu Irie , Masaki Suzuki , Yuko Hitomi , Atsushi Toyao
IPC分类号： A61K31/4545 , A61P9/12 , A61P9/10 , A61P9/04 , A61P27/02 , A61P13/12 , A61P1/16 , A61P25/28 , A61P25/22 , C07D401/12 , A61P9/00
CPC分类号： C07D401/12
摘要： The present invention relates to a compound of the formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations a compound of that class; a method of treatment comprising administering a compound of that class and a method for its manufacture.
摘要翻译：本发明涉及式I化合物，其中R1，R2，R3，R4和R5如说明书中所定义，用于诊断和治疗温血动物，特别是用于治疗疾病（=无效），依赖于肾素的活性; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 药物制剂是该类化合物; 一种治疗方法，包括施用该类化合物及其制备方法。

82. 发明授权

US08279346B2 Frame rate converting apparatus and method thereof 有权
标题翻译：帧率转换装置及其方法
公开(公告)号：US08279346B2
公开(公告)日：2012-10-02
申请号：US12499518
申请日：2009-07-08
申请人： Masaki Suzuki
发明人： Masaki Suzuki
IPC分类号： H04N5/21 , H04N5/00 , H04N11/20 , G06K9/40
CPC分类号： G06F3/1415 , G09G2320/02 , G09G2320/0261 , G09G2340/0435 , G09G2360/18 , H04N7/0132
摘要： In an image processing apparatus, degradation of edges of stationary subjects can be suppressed in a moving image obtained by converting moving image data having F frames per unit time into moving image data having 2F sub frames per the unit time. For this purpose, pixel data is inputted in order of raster scanning into an input terminal. Then three contiguous pixel data X1 to X3 are obtained by the input terminal and two delay circuits. A differentiator calculates a difference d1 (=X1−X2) between the pixel data of interest X2 and the neighbor pixel data X1 and a difference d2 (=X3−X2) between the pixel data of interest X2 and the neighbor pixel data X3. A multiplier coefficient for low-pass filter calculation is determined based on the differences d1 and d2, and pixel data X2′ is calculated as pixel data after filter-processing of the pixel data of interest X2.
摘要翻译：在图像处理装置中，通过将每单位时间具有F帧的运动图像数据转换成具有每单位时间2F子帧的运动图像数据而获得的运动图像，可以抑制静止被摄体的边缘的劣化。为此，将像素数据按照光栅扫描的顺序输入到输入端。然后通过输入端和两个延迟电路获得三个连续像素数据X1至X3。微分器计算感兴趣的像素数据X2和相邻像素数据X1之间的差值d1（= X1-X2）和感兴趣的像素数据X2与相邻像素数据X3之间的差值d2（= X3-X2）。基于差分d1和d2确定低通滤波器计算的乘数系数，并且在对感兴趣的像素数据X2进行滤波处理之后，将像素数据X2'计算为像素数据。

83. 发明申请

US20120140316A1 OPTICAL BODY, WINDOW MEMBER, FITTING, AND SOLAR SHADING DEVICE 有权
标题翻译：光学体系，窗户会员，配件和太阳能遮光装置
公开(公告)号：US20120140316A1
公开(公告)日：2012-06-07
申请号：US13155620
申请日：2011-06-08
申请人： Masaki Suzuki , Tsutomu Nagahama , Hiroya Takenaka , Masashi Enomoto
发明人： Masaki Suzuki , Tsutomu Nagahama , Hiroya Takenaka , Masashi Enomoto
IPC分类号： G02B5/08
CPC分类号： G02B5/208
摘要： An optical body includes a first optical layer having a concave-convex surface, a wavelength-selective reflecting layer formed on the concave-convex surface, and a second optical layer formed on the wavelength-selective reflecting layer to embed the concave-convex surface, the wavelength-selective reflecting layer having a multilayer structure formed by successively stacking at least a first high refractive index layer, a metal layer, and a second high refractive index layer, wherein, given that optical film thicknesses of the first high refractive index layer and the second high refractive index layer are x and y, respectively, and a geometrical film thickness of the metal layer is z, x, y and z satisfy the following formula (1): z ≤ 12.1  exp  { - 1 2  ( x - 120 145.17 ) 2 - 1 2  ( y - 120 123.14 ) 2 } ( 1 )
摘要翻译：光学体包括具有凹凸表面的第一光学层，形成在凹凸表面上的波长选择反射层和形成在波长选择反射层上以嵌入凹凸表面的第二光学层，所述波长选择反射层具有通过连续地堆叠至少第一高折射率层，金属层和第二高折射率层而形成的多层结构，其中，考虑到所述第一高折射率层和第二高折射率层分别为x和y，并且金属层的几何膜厚度为z，x，y和z满足下列公式（1）：z≤12.1exp exp { - 1 2 x - 120 145.17）2 - 1 2（y - 120 123.14）2}（1）

84. 发明授权

US08178559B2 Organic compounds 失效
标题翻译：有机化合物
公开(公告)号：US08178559B2
公开(公告)日：2012-05-15
申请号：US13176930
申请日：2011-07-06
申请人： Werner Breitenstein , Takeru Ehara , Claus Ehrhardt , Philipp Grosche , Yuko Hitomi , Yuki Iwaki , Takanori Kanazawa , Kazuhide Konishi , Juergen Klaus Maibaum , Keiichi Masuya , Atsuko Iwasaki , Nils Ostermann , Masaki Suzuki , Atsushi Toyao , Fumiaki Yokokawa
发明人： Werner Breitenstein , Takeru Ehara , Claus Ehrhardt , Philipp Grosche , Yuko Hitomi , Yuki Iwaki , Takanori Kanazawa , Kazuhide Konishi , Juergen Klaus Maibaum , Keiichi Masuya , Atsuko Iwasaki , Nils Ostermann , Masaki Suzuki , Atsushi Toyao , Fumiaki Yokokawa
IPC分类号： A61K31/451 , C07D211/60
CPC分类号： C07D471/04 , C07D211/60 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/10 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12
摘要： 3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4substituted piperidine compound, a method for the manufacture of a 3,4-substituted piperidine compound, and novel intermediates and partial steps for their synthesis are disclosed. The 3,4-disubstituted piperidine compounds have the formula (I), wherein the symbols have the meanings defined in the specification.
摘要翻译： 3,4-取代的哌啶化合物，这些化合物用于诊断和治疗温血动物，特别是用于治疗依赖于肾素活性的疾病（=病症）; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 包含3,4-取代的哌啶化合物的药物制剂和/或包括给药3,4代哌啶化合物的方法，制备3,4-取代的哌啶化合物的方法和新的中间体和部分步骤他们的合成被公开。 3,4-二取代的哌啶化合物具有式（I），其中符号具有说明书中定义的含义。

85. 发明授权

US08129411B2 Organic compounds 有权
标题翻译：有机化合物
公开(公告)号：US08129411B2
公开(公告)日：2012-03-06
申请号：US12159749
申请日：2006-12-28
申请人： Takeru Ehara , Philipp Grosche , Osamu Irie , Yuki Iwaki , Takanori Kanazawa , Shimpei Kawakami , Kazuhide Konishi , Muneto Mogi , Masaki Suzuki , Fumiaki Yokokawa
发明人： Takeru Ehara , Philipp Grosche , Osamu Irie , Yuki Iwaki , Takanori Kanazawa , Shimpei Kawakami , Kazuhide Konishi , Muneto Mogi , Masaki Suzuki , Fumiaki Yokokawa
IPC分类号： A61K31/454 , C07D401/02
CPC分类号： C07D401/12 , C07D211/60 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D413/14 , C07D471/04
摘要： The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis.The compounds have the formula I′ wherein R1, R2, T, R3 and R4 are as defined in the specification.
摘要翻译：本发明涉及3,5-取代的哌啶化合物，这些化合物用于诊断和治疗温血动物，特别是用于治疗依赖于肾素活性的疾病（=病症）; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 包含3,5-取代的哌啶化合物的药物制剂和/或治疗方法，包括给予3,5-取代的哌啶化合物，制备3,5-取代的哌啶化合物的方法，以及新的中间体和部分其合成步骤。化合物具有式I'，其中R 1，R 2，T，R 3和R 4如说明书中所定义。

86. 发明申请

US20110263560A1 Organic Compounds 失效
标题翻译：有机化合物
公开(公告)号：US20110263560A1
公开(公告)日：2011-10-27
申请号：US13176930
申请日：2011-07-06
申请人： Werner BREITENSTEIN , Takeru EHARA , Claus EHRHARDT , Philipp GROSCHE , Yuko HITOMI , Yuki IWAKI , Takanori KANAZAWA , Kazuhide KONISHI , Juergen Klaus MAIBAUM , Keiichi MASUYA , Atsuko Nihonyanagi , Nils OSTERMANN , Masaki SUZUKI , Atsushi TOYAO , Fumiaki YOKOKAWA
发明人： Werner BREITENSTEIN , Takeru EHARA , Claus EHRHARDT , Philipp GROSCHE , Yuko HITOMI , Yuki IWAKI , Takanori KANAZAWA , Kazuhide KONISHI , Juergen Klaus MAIBAUM , Keiichi MASUYA , Atsuko Nihonyanagi , Nils OSTERMANN , Masaki SUZUKI , Atsushi TOYAO , Fumiaki YOKOKAWA
IPC分类号： A61K31/4523 , C07D401/10 , C07D401/12 , C07D413/12 , C07D413/04 , A61P9/12 , C07D417/12 , A61K31/451 , A61K31/4545 , A61K31/454 , A61K31/538 , A61K31/5415 , C07D211/60 , C07D405/12
CPC分类号： C07D471/04 , C07D211/60 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/10 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12
摘要： 3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4substituted piperidine compound, a method for the manufacture of a 3,4-substituted piperidine compound, and novel intermediates and partial steps for their synthesis are disclosed. The 3,4-disubstituted piperidine compounds have the formula (I), wherein the symbols have the meanings defined in the specification.
摘要翻译： 3,4-取代的哌啶化合物，这些化合物用于诊断和治疗温血动物，特别是用于治疗依赖于肾素活性的疾病（=病症）; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 包含3,4-取代的哌啶化合物的药物制剂和/或包括给药3,4代哌啶化合物的方法，制备3,4-取代的哌啶化合物的方法和新的中间体和部分步骤他们的合成被公开。 3,4-二取代的哌啶化合物具有式（I），其中符号具有说明书中定义的含义。

87. 发明申请

US20110021112A1 TOY MODEL WITH TRANSFORMING TIRE MECHANISM 审中-公开
标题翻译：具有改变轮胎机制的玩具模型
公开(公告)号：US20110021112A1
公开(公告)日：2011-01-27
申请号：US12842248
申请日：2010-07-23
申请人： MASAKI SUZUKI
发明人： MASAKI SUZUKI
IPC分类号： A63H17/00
CPC分类号： A63H17/262 , A63H30/04
摘要： In accordance with one implementation of the present principles, the toy model tires are designed to be divided into sections. Each divided tire section independently pivots on its own fixed fulcrum point. In response to terrain conditions, the tires can transform by the pivoting of the tire sections outward, thus increasing the outer diameter and causing the tire to take on a claw like form to assist in overcoming rough terrain or obstacles on a running surface.
摘要翻译：根据本原理的一个实现，玩具模型轮胎被设计成分为几个部分。每个分开的轮胎部分独立地在其固定的支点上枢转。响应于地形条件，轮胎可以通过向外的轮胎部分的枢转而变换，从而增加外径，并使轮胎采取爪状的形式，以帮助克服行驶表面上的崎岖地形或障碍物。

88. 发明申请

US20090192148A1 Organic Compounds 有权
标题翻译：有机化合物
公开(公告)号：US20090192148A1
公开(公告)日：2009-07-30
申请号：US12159749
申请日：2006-12-28
申请人： Takeru Ehara , Philipp Grosche , Osamu Irie , Yuki Iwaki , Takanori Kanazawa , Shimpei Kawakami , Kazuhide Konishi , Muneto Mogi , Masaki Suzuki , Fumiaki Yokokawa
发明人： Takeru Ehara , Philipp Grosche , Osamu Irie , Yuki Iwaki , Takanori Kanazawa , Shimpei Kawakami , Kazuhide Konishi , Muneto Mogi , Masaki Suzuki , Fumiaki Yokokawa
IPC分类号： A61K31/536 , C07D401/02 , C07D265/36 , C07D471/04 , A61K31/4725 , A61P43/00 , A61K31/437 , C07D215/20 , A61K31/454
CPC分类号： C07D401/12 , C07D211/60 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D413/14 , C07D471/04
摘要： The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis.The compounds have the formula I′ wherein R1, R2, T, R3 and R4 areas defined in the specification.
摘要翻译：本发明涉及3,5-取代的哌啶化合物，这些化合物用于诊断和治疗温血动物，特别是用于治疗依赖于肾素活性的疾病（=病症）; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 包含3,5-取代的哌啶化合物的药物制剂和/或治疗方法，包括给予3,5-取代的哌啶化合物，制备3,5-取代的哌啶化合物的方法，以及新的中间体和部分其合成步骤。化合物具有式I'，其中在说明书中定义的R1，R2，T，R3和R4区域。

89. 发明申请

US20080040125A1 Apparatus for Revising Corporate Checklist 审中-公开
标题翻译：修改公司清单的设备
公开(公告)号：US20080040125A1
公开(公告)日：2008-02-14
申请号：US10594035
申请日：2005-03-18
申请人： Nobutaka Okabe , Masayuki Satou , Ichirou Hayashi , Hirofumi Kosaka , Masaki Suzuki , Satoko Sakurai
发明人： Nobutaka Okabe , Masayuki Satou , Ichirou Hayashi , Hirofumi Kosaka , Masaki Suzuki , Satoko Sakurai
IPC分类号： G06Q10/00
CPC分类号： G06Q10/06 , G06Q30/018
摘要： An apparatus for supporting revision of a checklist for checking soundness of a company in accordance with revision of the laws and ordinances is provided. The apparatus comprises a first database of a checklist containing check items associated with provisions of laws/ordinances, a second database of laws/ordinances data including texts of provisions, and a computer for supporting revision of the checklist responsive to entry of revision of laws/ordinances. The computer is programmed to produce revision information indicating deletion, addition or updating of respective provisions of the revised laws and ordinances. The computer deletes from/add to the checklist a name of a provision of the laws/ordinances identified by the revision information, and delete a relevant check item when the revision information indicates deletion/add to the checklist a check item associated with the revised provision when the revision information indicates deletion.
摘要翻译：提供了一种根据法令修订来支持修改公司检查清单的设备。该装置包括第一个包含与法律条款相关的检查项目的清单的数据库，包括规定文本的法律/法规数据的第二数据库和用于支持对修订法律/ 条例。计算机被编程为产生修改信息，指示删除，添加或更新修订法律法规的各项规定。计算机从清单中删除修改信息确定的法律/条例规定的名称，当修订信息表示删除/添加到清单中时，删除相关检查项目与修订规定相关联的检查项目当修订信息表示删除时。

90. 发明授权

US07317985B2 Motor vehicle and control method of motor vehicle 有权
标题翻译：机动车辆及机动车辆的控制方法
公开(公告)号：US07317985B2
公开(公告)日：2008-01-08
申请号：US11667271
申请日：2005-11-24
申请人： Masaki Suzuki
发明人： Masaki Suzuki
IPC分类号： G06F19/00 , F02D41/00
CPC分类号： B60W20/15 , B60H1/004 , B60H1/00764 , B60K6/445 , B60W10/06 , B60W10/08 , B60W10/30 , B60W20/00 , B60W2710/086 , F02D29/02 , F02D41/06 , F02N11/084 , F02N2200/0806 , Y02T10/48 , Y02T10/6239 , Y02T10/6286
摘要： When a vehicle power demand is less than a threshold value, which is set to or around a lower limit of a relatively efficient drive range of an engine and when an engine drive demand is set ON because of requirement for heating by an air conditioning system, the drive control of the invention sets the threshold value to an engine power demand and sets a higher level than a standard level to a maximum SOC (state of charge) of a battery. This drive control starts load operation of the engine with charge of the battery. The load operation of the engine desirably improves the fuel consumption of the vehicle, compared with independent operation of the engine.
摘要翻译：当车辆功率需求小于设定在发动机的相对有效的驱动范围的下限或其周围的阈值时，并且当由于空调系统的加热要求而将发动机驱动要求设定为ON时，本发明的驱动控制将阈值设定为发动机功率需求，并将比标准电平更高的电平设置为电池的最大SOC（充电状态）。该驱动控制开始负载电池的负载运行。与发动机的独立操作相比，发动机的负载操作期望地改善了车辆的燃料消耗。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式